Description of Conduct
On 10 May 2024, GEMPASS Australia Limited (GEMPASS Australia), formerly GAMSAT Consortium Limited, lodged an application to revoke authorisations A91441, A91442, A91443 (as varied by the determination dated 16 June 2021) and substitute authorisation AA1000672 for the ones revoked.
GEMPASS Australia sought revocation and substitution in order to collectively develop and administer a shared approach to managing applications for entry to graduate-level medical schools that are members of GEMPASS Australia. GEMPASS Australia currently has 9 university members, being The University of Wollongong, Deakin University, The University of Western Australia, Griffith University, The University of Notre Dame Australia, The Australian National University, The University of Queensland, The University of Melbourne and Macquarie University.
GEMPASS Australia sought authorisation for 10 years.
On 12 September 2024, the ACCC issued a draft determination proposing to grant authorisation for 10 years.
On 23 October 2024, the ACCC issued a final determination granting authorisation for 10 years, until 14 November 2034.
The ACCC’s final determination, draft determination and the application for authorisation are available below.
Applicant(s)
- GEMPASS AUSTRALIA LIMITED
Applications
Decisions
| Document title | Date | |
|---|---|---|
| Final Determination | ||
| Draft Determination |